Abstract:BACKGROUND:Intracerebral hemorrhage (ICH) often impacts patient white matter. However, preclinically, the effects of ICH are mostly studied in rodents with sparse white matter. This study used a lobar porcine ICH model to examine differences in the effects of ICH on white and gray matter as well as the role of the iron chelator deferoxamine (DFX), on attenuation of such injury. METHODS:This two-part study was performed in piglets. Firstly, piglets had a needle (Sham) or 2.5 ml blood injection (ICH) and were euthanized at day 3. Secondly, animals were treated with vehicle or DFX after ICH and were euthanized at day 3. White and gray matter edema, the number of oligodendrocytes (mature and immature) and neurons, and the number of Perls' (iron), ferritin and heme oxygenase (HO)-1 positive cells were examined. RESULTS:At day 3, ICH induced greater edema formation in white than gray matter. This marked white matter edema was associated with a loss of mature, but not immature, oligodendrocytes. ICH also induced neuronal death in gray matter. There were also marked increases in Perls', ferritin and HO-1 positive cells after ICH in both white and gray matter, but significantly more in the former. DFX attenuated ICH-induced brain edema in white but not gray matter and this was associated with increased survival of mature oligodendrocytes. DFX also increased survival of neurons in the gray matter and it reduced the number of Perls', ferritin and HO-1 positive cells in both tissue types. CONCLUSIONS:While there were commonalities in perihematomal changes between white and gray matter after ICH, there was greater edema in white matter which may be linked to the susceptibility of mature oligodendrocytes to ICH injury. Similarly, while DFX reduced perihematomal iron overload in both white and gray matter, it only significantly reduced edema in white matter where it increased the number of mature oligodendrocytes.

Deferoxamine reduces intracerebral hemorrhage-induced white matter damage in aged rats

Deferoxamine Affects Heat Shock Protein Expression in Heart after Intracerebral Hemorrhage in Aged Rats

Deferoxamine Reduces Neuronal Death and Hematoma Lysis After Intracerebral Hemorrhage in Aged Rats

Deferoxamine Reduces CSF Free Iron Levels Following Intracerebral Hemorrhage

Iron Accumulation And Dna Damage In A Pig Model Of Intracerebral Hemorrhage

Effects of Deferoxamine on Intracerebral Hemorrhage-Induced Brain Injury in Aged Rats

Activation of C-Jun-n-terminal Kinase in a Rat Model of Intracerebral Hemorrhage: the Role of Iron.

Deferoxamine Attenuates White Matter Injury in a Piglet Intracerebral Hemorrhage Model

Deferoxamine inhibits microglial activation, attenuates blood-brain barrier disruption, rescues dendritic damage and improves spatial memory in a mouse model of microhemorrhages.

Efficacy of Deferoxamine in Animal Models of Intracerebral Hemorrhage: A Systematic Review and Stratified Meta-Analysis

Comparing White and Gray Matter Responses to Lobar Intracerebral Hemorrhage in Piglets and the Effects of Deferoxamine

Deferoxamine Reduces Intracerebral Hematoma-Induced Iron Accumulation and Neuronal Death in Piglets

The combination of deferoxamine and minocycline strengthens neuroprotective effect on acute intracerebral hemorrhage in rats

Deferoxamine Alleviates Iron Overload and Brain Injury in a Rat Model of Brainstem Hemorrhage

Iron Toxicity in Mice with Collagenase-Induced Intracerebral Hemorrhage

Deferoxamine therapy for intracerebral hemorrhage: A systematic review

Iron Neurotoxicity and Protection by Deferoxamine in Intracerebral Hemorrhage

Iron chelator-Deferoxamine attenuated hemorrhagic transformation in a rat model of transient focal cerebral ischemia

Hemoglobin and Iron Handling in Brain after Subarachnoid Hemorrhage and the Effect of Deferoxamine on Early Brain Injury

Effects of statin and deferoxamine administration on neurological outcomes in a rat model of intracerebral hemorrhage